finnCap - Life Sciences quarterly sector note

In light of the Brexit vote, finnCap reflect upon the implications for the NHS and the wider healthcare industry. They take a pragmatic approach to how the referendum result will affect staffing, recruitment, clinical trials, drug pricing and small company grant funding in the coming months and years.

Mark Brewer
Research Director Life Sciences

Company Events - FINNCAP